Masso Torrence Wealth Management Inc. Acelrx Pharmaceuticals Inc Transaction History

Masso Torrence Wealth Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 26, 2022	SELL	$0.28 - $0.61 $700 - $1,525	-2,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$0.49 - $1.02 $1,225 - $2,550	2,500 New	2,500 $1,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Masso Torrence Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Masso Torrence Wealth Management Inc. with notifications on news.